Column Group II GP, LP is Director & 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 4 open-market trades across 1 company since 2019, most recently 2023-01-20.
CIK 0001645333
4 open-market purchases totalling $1.6M since 2019, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.